BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9827720)

  • 1. Serous borderline tumors of the ovary with noninvasive peritoneal implants.
    Gershenson DM; Silva EG; Tortolero-Luna G; Levenback C; Morris M; Tornos C
    Cancer; 1998 Nov; 83(10):2157-63. PubMed ID: 9827720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian serous borderline tumors with invasive peritoneal implants.
    Gershenson DM; Silva EG; Levy L; Burke TW; Wolf JK; Tornos C
    Cancer; 1998 Mar; 82(6):1096-103. PubMed ID: 9506355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery as sole treatment for serous borderline tumors of the ovary with noninvasive implants.
    Lackman F; Carey MS; Kirk ME; McLachlin CM; Elit L
    Gynecol Oncol; 2003 Aug; 90(2):407-12. PubMed ID: 12893209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary surgery in patients with serous low malignant potential ovarian tumors with peritoneal implants.
    Kane A; Uzan C; Rey A; Gouy S; Duvillard P; Morice P
    Int J Gynecol Cancer; 2010 Apr; 20(3):346-52. PubMed ID: 20375795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion.
    Prat J; De Nictolis M
    Am J Surg Pathol; 2002 Sep; 26(9):1111-28. PubMed ID: 12218568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases.
    Vang R; Hannibal CG; Junge J; Frederiksen K; Kjaer SK; Kurman RJ
    Am J Surg Pathol; 2017 Jun; 41(6):725-737. PubMed ID: 28248817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grade 1 peritoneal serous carcinomas: a report of 14 cases and comparison with 7 peritoneal serous psammocarcinomas and 19 peritoneal serous borderline tumors.
    Weir MM; Bell DA; Young RH
    Am J Surg Pathol; 1998 Jul; 22(7):849-62. PubMed ID: 9669347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumors.
    Gershenson DM; Deavers M; Diaz S; Tortolero-Luna G; Miller BE; Bast RC; Mills GB; Silva EG
    Clin Cancer Res; 1999 Dec; 5(12):4053-8. PubMed ID: 10632339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns.
    Eichhorn JH; Bell DA; Young RH; Scully RE
    Am J Surg Pathol; 1999 Apr; 23(4):397-409. PubMed ID: 10199469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential.
    Crispens MA; Bodurka D; Deavers M; Lu K; Silva EG; Gershenson DM
    Obstet Gynecol; 2002 Jan; 99(1):3-10. PubMed ID: 11777502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical behavior of serous and mucinous borderline tumors of the ovary with diploid DNA stem line. Follow-up studies after organ preserving and non-organ preserving therapy].
    Mecke H; Börner-Klaussner B; Grosse G; Nadjari B; Hauptmann S
    Zentralbl Gynakol; 2000; 122(5):274-9. PubMed ID: 10857214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian serous borderline tumors with noninvasive and invasive peritoneal implants: A case report each.
    Srinivasamurthy BC; Kulandai Velu AR; Krishnan N; Patil AS
    J Cancer Res Ther; 2015; 11(3):646. PubMed ID: 26458602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimplants in serous borderline tumors of the ovary: a clinicopathologic study of 30 cases of a process to be distinguished from serous adenocarcinoma.
    Rollins SE; Young RH; Bell DA
    Am J Surg Pathol; 2006 Apr; 30(4):457-62. PubMed ID: 16625091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of patients with advanced-stage borderline ovarian tumors after a first peritoneal noninvasive recurrence: impact on further management.
    Uzan C; Zanini-Grandon AS; Bentivegna E; Gouy S; Leary A; Duvillard P; Morice P
    Int J Gynecol Cancer; 2015 Jun; 25(5):830-6. PubMed ID: 25828751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant platinum-based chemotherapy for borderline serous ovarian tumors with invasive implants.
    Leary A; Petrella MC; Pautier P; Duvillard P; Uzan C; Tazi Y; Ledoux F; Gouy S; Morice P; Lhommé C
    Gynecol Oncol; 2014 Jan; 132(1):23-7. PubMed ID: 24219980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants.
    Kane A; Uzan C; Rey A; Gouy S; Camatte S; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Morice P
    Oncologist; 2009 Jun; 14(6):591-600. PubMed ID: 19487334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases.
    Deavers MT; Gershenson DM; Tortolero-Luna G; Malpica A; Lu KH; Silva EG
    Am J Surg Pathol; 2002 Sep; 26(9):1129-41. PubMed ID: 12218569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of secondary cytoreduction in low-grade serous ovarian cancer or peritoneal cancer.
    Crane EK; Sun CC; Ramirez PT; Schmeler KM; Malpica A; Gershenson DM
    Gynecol Oncol; 2015 Jan; 136(1):25-9. PubMed ID: 25448453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma.
    Shvartsman HS; Sun CC; Bodurka DC; Mahajan V; Crispens M; Lu KH; Deavers MT; Malpica A; Silva EG; Gershenson DM
    Gynecol Oncol; 2007 Jun; 105(3):625-9. PubMed ID: 17320156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.